{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:37:14Z","timestamp":1789385834011,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council (ARC) Linkage","doi-asserted-by":"publisher","award":["LP130100882"],"award-info":[{"award-number":["LP130100882"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jconrel.2016.06.045","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T14:07:32Z","timestamp":1467554852000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8 + T cell responses"],"prefix":"10.1016","volume":"237","author":[{"given":"Germain J.P.","family":"Fernando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwee-Ing","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar L.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally R.","family":"Yukiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.F.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.06.045_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123969","article-title":"Phase 1 study of pandemic H1 DNA vaccine in healthy adults","volume":"10","author":"Crank","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization*","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0020","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1128\/JVI.73.9.7877-7881.1999","article-title":"Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity","volume":"73","author":"Shi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.24333","article-title":"Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants","volume":"125","author":"Ohlschlager","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/cgt.2010.27","article-title":"Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection","volume":"17","author":"Haigh","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1750-2659.2007.00010.x","article-title":"Protection against mouse and avian influenza a strains via vaccination with a combination of conserved proteins NP, M1 and NS1","volume":"1","author":"Zhirnov","year":"2007","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0040","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.160.4.1717","article-title":"Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination","volume":"160","author":"Thomson","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0045","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091366","article-title":"Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (IM), subcutaneous (SC) and intradermal (ID) administration (VRC 011)","volume":"9","author":"Enama","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials","volume":"11","author":"Ledgerwood","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0065","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/mt.2012.69","article-title":"DNA vaccination in the skin using microneedles improves protection against influenza","volume":"20","author":"Song","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.0022-202X.2004.22320.x","article-title":"Effects of relative humidity and ambient temperature on the ballistic delivery of micro-particles to excised porcine skin","volume":"122","author":"Kendall","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0075","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jbiomech.2004.01.032","article-title":"Intradermal ballistic delivery of micro-particles into excised human skin for pharmaceutical applications","volume":"37","author":"Kendall","year":"2004","journal-title":"J. Biomech."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd2076","article-title":"Current status and future prospects of needle-free liquid jet injectors","volume":"5","author":"Mitragotri","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0085","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0090","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2005.08.067","article-title":"Assessment of epidermal cell viability by near infrared multi-photon microscopy following ballistic delivery of gold micro-particles","volume":"24","author":"Raju","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2009.10.013","article-title":"Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity","volume":"142","author":"Kim","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0100","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/smll.201000331","article-title":"Nanopatch-targeted skin vaccination against West Nile virus and Chikungunya virus in mice","volume":"6","author":"Prow","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jconrel.2009.11.005","article-title":"Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system","volume":"142","author":"Yamaoka","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0110","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1016\/j.vaccine.2010.09.014","article-title":"DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge","volume":"28","author":"Kask","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jconrel.2010.09.001","article-title":"Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays","volume":"148","author":"Chen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0125","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1073\/pnas.90.24.11478","article-title":"DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations","volume":"90","author":"Fynan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0264-410X(95)00069-D","article-title":"Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA","volume":"13","author":"Pertmer","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.159.1.11","article-title":"The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites","volume":"159","author":"Iwasaki","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0140","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.188.6.1075","article-title":"Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after Gene gun immunization","volume":"188","author":"Porgador","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0145","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1099\/0022-1317-80-10-2559","article-title":"Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein","volume":"80","author":"Chen","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0264-410X(99)00279-0","article-title":"Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza a virus HA and NP CTL-epitopes","volume":"18","author":"Fomsgaard","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpb.2012.03.010","article-title":"Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch","volume":"81","author":"Kim","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jconrel.2013.04.016","article-title":"Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles","volume":"172","author":"Kim","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010266","article-title":"Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model","volume":"5","author":"Fernando","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2012.01.030","article-title":"Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses","volume":"159","author":"Fernando","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0175","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/jid.2014.174","article-title":"Co-localization of cell death with antigen deposition in skin enhances vaccine immunogenicity","volume":"134","author":"Depelsenaire","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0180","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/nature05379","article-title":"The mechanism by which influenza a virus nucleoprotein forms oligomers and binds RNA","volume":"444","author":"Ye","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0185","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1039\/c2ra20153d","article-title":"High density and high aspect ratio solid micro-nanoprojection arrays for targeted skin vaccine delivery and specific antibody extraction","volume":"2","author":"Jenkins","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2009.06.029","article-title":"Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin","volume":"139","author":"Chen","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2012.12.010","article-title":"Depth-resolved characterization of diffusion properties within and across minimally-perturbed skin layers","volume":"166","author":"Raphael","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0200","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.161.5.2421","article-title":"Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model","volume":"161","author":"Fernando","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0205","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(86)90019-X","article-title":"The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides","volume":"44","author":"Townsend","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0210","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1073\/pnas.95.23.13812","article-title":"Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia","volume":"95","author":"Belz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0215","first-page":"2810","article-title":"Peripheral tolerance to human papillomavirus E7 Oncoprotein occurs by cross-Tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization","volume":"60","author":"Doan","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0220","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2796.2011.02367.x","article-title":"Hallmarks of CD4 T cell immunity against influenza","volume":"269","author":"McKinstry","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0225","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.02508-09","article-title":"Cytotoxic T cells are the predominant players providing cross-protective immunity induced by gamma-irradiated influenza a viruses","volume":"84","author":"Furuya","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2011.10.021","article-title":"A conserved matrix epitope based DNA vaccine protects mice against influenza a virus challenge","volume":"93","author":"Kumar","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0235","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/gt.2011.59","article-title":"Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination","volume":"18","author":"Fagone","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jconrel.2012.07.024","article-title":"Induction of potent CD8+ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays","volume":"162","author":"Ng","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0245","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pharmthera.2008.08.007","article-title":"Killer T cells in influenza","volume":"120","author":"Stambas","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076407","article-title":"A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice","volume":"8","author":"Dutton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.045_bb0255","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/cgt.2014.56","article-title":"Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model","volume":"21","author":"Yan","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0260","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1073\/pnas.0603289103","article-title":"Early establishment of diverse T cell receptor profiles for influenza-specific CD8(+)CD62L(hi) memory T cells","volume":"103","author":"Kedzierska","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.06.045_bb0265","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916304229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916304229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:19:12Z","timestamp":1692415152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916304229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":53,"alternative-id":["S0168365916304229"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.045","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8+ T cell responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}